Moscow, September 16. Specialists at the Sechenov University…

Moscow, September 16. Specialists at the Sechenov University successfully applied an innovative Chinese targeted immunooncological drug to treat a patient with stage four nasopharyngeal cancer.

Coverage (2 sources)

Key entities